Tinea capitis;Tinea capitis

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 12, 2006, Pages 1085-1091

  Seebacher, Claus ^a   Abeck, Dietrich ^a   Brasch, Jochen ^a   Cornely, Oliver ^a   Daeschlein, Georg ^a   Effendy, Isaak ^a   Ginter Hanselmayer, Gabriele ^a   Haake, Norbert ^a   Hamm, Gudrun ^a   Hipler, Uta Christina ^a   Hof, Herbert ^a   Korting, Hans Christian ^a   Kramer, Axel ^a   Mayser, Peter ^a   Ruhnke, Markus ^a   Schlacke, Kurt Heiner ^a   Tietz, Hans Jürgen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIADA; CICLOPIROXOLAMINE; CLOTRIMAZOLE; DERMATIN; DERMGEL; FLUCOBETA; FLUCODERM; FLUCOLICH; FLUCONAZOL DERM 50; FLUCONAZOLE; FUNAZUL; FUNGICIDE; GRISEOFULVIN; ITRACOL; ITRACONAZOLE; MYCONORMIN; OCTOSAN; ONYMAX; POVIDONE IODINE; SEBIPROX; SELENIUM SULFIDE; TERBIDERM; TERBIGALEN; TERBINAFIN; TERBINAFINE; TOLCICLATE; TOLNAFTATE;

ADJUVANT THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FUNGUS CULTURE; HUMAN; LABORATORY DIAGNOSIS; MICROSPORUM CANIS; NONHUMAN; ONYCHOMYCOSIS; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; TINEA CAPITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON VERRUCOSUM;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; GRISEOFULVIN; HUMANS; ITRACONAZOLE; NAPHTHALENES; POVIDONE-IODINE; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; SOAPS; TIME FACTORS; TINEA CAPITIS; TREATMENT OUTCOME;

EID: 33845594481     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.06133.x     Document Type: Review

References (32)

1. Aste N, Pau M, Biggio P: Tinea capitis in children in the district of Cagliari, Italy. mycoses 1997; 40: 231-233.
2. Cauwenbergh G, Degreef H, Heykants J, Woestenborghs R, Van Rooy P, Haeverans K: Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263-268.
3. Dasghaib L, Azizzadeh M, Jafari P: Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. J Dermatol Treatm. 2005; 16: 43-46.
4. Desinfektionsmittel-Liste des VAH. mhp Wiesbaden, 2006.
5. Dragos V, Lunder M: Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dermatol 1997; 14: 46-48.
6. Elewski B E: Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1-20.
7. Faergemann J, Zehender H, Jones T, Maibach I: Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol (Stockh) 1991; 71: 322-326.
8. Fleece D, Gaughan JP, Aronoff SC: Griseofulvin versus terbinafine in treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics 2004; 114: 1312-1315.
9. Friedlander SF: Treating tinea capitis with terbinafine: latest findings. JEADV 2001; 15 (Suppl 2) 99 (Abstract).
10. Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P, Stewart D, Lucky AW, Gupta AK, Babel DE, Abrams B, Gourmala N, Wraith LA, Paul C, and Tinea Capitis Study Group: Terbinafine in the treatment of Trichophyton tinea capitis: A randomized, double-blind, parallel-group, duration-finding study. Pediatrics 2002; 109:602-607.
11. Ginter-Hanselmayer G, Smolle J, Gupta A: Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediat. Dermatol. 2004; 21: 499-502.
12. Gupta AK, Grooen K, Woestenborghs R, De Doncker P: Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Clin Experim Derma-tol 1998; 23: 103-108.
13. Gupta AK, Hofstader SLR, Adam P, Summerbell RC: Tinea capitis: an overview with emphasis on management. Pediatr Dermatol 1999; 16: 171-189.
14. Gupta AK, Summerbell RC: Tinea capitis. Medical Mycology 2000; 38: 255-287
15. Gupta AK, Ginter G: Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Pediatr Dermatol 2001; 18: 519-522.
16. Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, Aboobaker J, Sum-merbell RC: Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: Griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001; 18: 433-438.
17. Gupta AK, Ahmad I, Summerbell RC: Comparative efficacies of commonly used disin-fectants and antifungal pharmaceutical spray preparations against dermatophytic fungi. Med Mycology 2001; 39: 321-328.
18. Haase G., Borg-von Zepelin M., Bernhardt H., Fegeler W., Harmsen D., Kappe R., Korting H.C., Kuijpers A., Schaller M., Schmalreck A., Seebacher C., Tintelnot K:. Qualitätsstandards in der mikrobiologischen Diagnostik. Pilzinfektionen Teil I Präanalytik, Analytik (MiQ 14), Pilzinfektionen Teil II Spezielle Pilzdiagnostik (MiQ 15). München Jena, Urban & Fischer 2002..
19. Higgins, E M, Fuller, L C, Smith C H: Guidelines for management of tinea capitis. Br J Dermatol 2000; 143: 53-58.
20. Kefalidou S, Odia S, Gruseck E, Schmidt T, Ring J, Abeck D: Wood's light in Mic-rosporum canis positive patients. mycoses 1997; 40: 461-463.
21. Kramer A, Daeschlein G, Kammerlander G, Andriessen A, Aspöck C, Bergemann R, Eberlein T, Gerngross H, Görtz G, Heeg P, Jünger M, Koch S, König B, Laun R, Peter RU, Roth B, Ruef C, Sellmer W, Wewalka G, Eisenbeiß W (2004) Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundantiseptik. Hyg Med 5: 147-157;
22. ZfW 3: 110-120.
23. López-Gómez S, Del Palazio A: Itraconazole versus griseofulvin in the treatment of tinea capitis: A double-blind randomized study in children. Int J Dermatol 1994; 33: 743-747.
24. Möhrenschlager M, Seidl HP, Ginter-Hanselmayer G, Abeck D: Tinea capitis of child-hood: incidence and pathogenetic role of Trichophyton tonsurans in Central Europe. J Am Acad Dermatol 2001; 45: 320
25. Montero-Gei F: Fluconazole in the treatment of tinea capitis. Intern J Dermatol 1998; 37: 870-873.
26. Otberg N, Tietz H-J, Henz B M, Haas N: Kerion due to Trichophyton mentagrophytes: responsiveness to fluconazole versus terbinafine in a child. Acta Derm Venereol 2001; 81: 444-445.
27. Roberts BJ, Friedlander SF: Tinea capitis: a treatment update. Pediatric Ann 2005; 34: 191-200.
28. Schwinn A, Ebert J, Bröcker E B: Frequency of T. rubrum in tinea capitis. mycoses 1995; 38: 1-7.
29. Seebacher C.: Grenzen der Kurzzeitbehandlung von Onychomykosen. Hautarzt 1998; 49: 705-708.
30. Tietz HJ, Ulbricht HM, Sterry W: Tinea capitis in Deutschland - Ergebnisse einer epidemiologischen Analyse. Z Hautkr 1999; 74: 683-688.
31. Tietz HJ, Sterry W: Antimykotika von A - Z Klinik und Pharmakologie auf einen Blick. 4. Auflage, Stuttgart New York, Thieme 2006.
32. Wildfeuer A, Faergemann J, Laufen H, Pfaff G, Zimmermann T, Seidl HP, Lach P: Bioavailability of fluconazole in the skin after oral medication. mycoses 1994; 37: 127-130.